New venture capital firm age1 aims to extend healthy lifespan
Longevity Technology - 22-Sep-2023Investing in the next generation of longevity biotech companies
Join the club for FREE to access the whole archive and other member benefits.
Venture capitalist with focus on life extension
Laura Deming is a venture capitalist. Her work focuses on life extension, and using biological research to reduce or reverse the effects of aging.
Laura Deming is the daughter of John and Tabitha Deming; she grew up in New Zealand. Deming and her brother, Trey, were homeschooled; she says she taught herself "calculus and probability and statistics, and French literature and history." At age 8, Deming became interested in the biology of aging, and at age 12 she joined the lab of Cynthia Kenyon at the University of California, San Francisco. Kenyon successfully increased the lifespan of the worm C. elegans by a factor of ten through genetic engineering. Deming was accepted to MIT at age 14 and studied physics, but later dropped out to accept the $100,000 Thiel Fellowship and start a venture capital firm. Deming was one of only two women in the 2011 initial class of Thiel Fellows.
Visit website: https://www.ldeming.com/
See also: Longevity Fund - Venture capital firm investing in longevity companies, life sciences, digital health and other longevity related fields
Details last updated 19-Nov-2020
Laura Deming's overview of the longevity for beginners
Investing in the next generation of longevity biotech companies
Connecting aspiring longevity founders with mentors to drive innovation in anti-ageing biotech